Billionaire triumvirate announces bold plan to disrupt US healthcare

31 January 2018
mergers-acquisitions-big

Three corporate behemoths have hatched a plan to step in to the American healthcare market, with the aim of “improving employee satisfaction and reducing costs.”

Digital colossus Amazon has teamed up with financier JPMorgan Chase and sprawling conglomerate Berkshire Hathaway to create “an independent company that is free from profit-making incentives and constraints.”

The firms will focus on “technology solutions that will provide US employees and their families with simplified, high-quality and transparent healthcare at a reasonable cost.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical